References
- Araújo LMTD, Garcia LV. 2013. Acute normovolemic hemodilution: a practical approach. Open J Anesthesiol. 3:38–43.
- Bonegio RG, Fuhro R, Ragno G, Valeri C, Lieberthal W. 2009. A comparison of the acute hemodynamic and delayed effects of 50% exchange transfusion with two different cross-linked hemoglobin based oxygen carrying solutions and pentastarch. Artif Cells Blood Substit Biotechnol. 34:145–157.
- Bucci E, Kwansa H, Koehler RC. 2009. Development of zero-link polymers of hemoglobin, which do not extravasate and do not induce pressure increases upon infusion. Artif Cells Blood Substit Biotechnol. 35:11–18.
- Cabrales P, Meng F, Acharya SA. 2010. Tissue oxidative metabolism after extreme hemodilution with PEG-conjugated hemoglobin. J Appl Physiol. 109:1852–1859.
- Carson JL, Noveck H, Berlin JA, Gould SA. 2002. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion. 42:812–818.
- Ezejindu DN, Chinweife KC, Ihentuge CJ. 2013. The effects of moringa extract on liver enzymes of carbon tetrachloride induced hepatotoxicity in adult Wister rats. Int J Eng Sci. 2:54–59.
- George JC 2015. Regional tolerance to acute normovolemic hemodilution: evidence that the kidney may be at greatest risk. J Cardiothorac Vasc Anesth. 29:320–327.
- Gould SA, Moore EE, Moore FA, Haenel JB, Burch JM, Sehgal H, et al. 1997. Clinical utility of human polymerized hemoglobin as a blood substitute after acute trauma and urgent surgery. J Trauma. 43:325–332.
- Harrington JP, Kobayashi S, Dorman SC. 2007. Acellular invertebrate hemoglobins as model therapeutic oxygen carriers: unique redox potentials. Artif Cells Blood Substit Immobil Biotechnol. 35:53–67.
- Ickx BE, Rigolet M, Van Der Linden PJ. 2000. Cardiovascular and metabolic response to acute normovolemic anemia. Effects of anesthesia. Anesthesiology. 93:1011–1016.
- Mackenzie CF, Moon-Massat PF, Shander A, Javidroozi M, Greenburg AG. 2010. When blood is not an option: factors affecting survival after the use of a hemoglobin-based oxygen carrier in 54 patients with life-threatening anemia. Anesth Analg. 110:685–693.
- Moore EE, Moore FA, Fabian TC, Bernard AC, Fulda GJ, Hoyt DB, et al. 2009. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg. 208:1–13.
- Muir WW, Ilangovan G, Zweier JL, oonmassat PF, Rentko VT. 2011. Vital organ tissue oxygenation after serial normovolemic exchange transfusion with HBOC-201 in anesthetized swine. Shock. 35:597–603.
- Murray D. 2004. Acute normovolemic hemodilution. Eur Spine J. 13:72–75.
- Steven NV, Brian JK, Talarico TL. 2001. Oxygen transport dynamics of acellular hemoglobin solutions in an isovolemic hemodilution model in swine. J Trauma. 51:1153–1160.
- Vallet B. 2010. Venous oxygen saturation as a physiologic transfusion trigger. Crit Care. 14:1–5.
- Walsh TS, Lee RJ, Maciver CR, Garrioch M, Mackirdy F, Binning AR, Cole S, McClelland DB. 2006. Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice. Intensive Care Med. 32:100–109.
- Wu W, Rathore S, Wang Y, Radford M, Krumholz H. 2001. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 345:1230–1236.
- Young MA, Lohman J, Malavalli A. 2009. Hemospan improves outcome in a model of perioperative hemodilution and blood loss in the rat: comparison with hydroxyethyl starch. J Cardiothorac Vasc Anesth. 23:339–347.
- Zhang W, Yan KP, Dai PG, Tian JJ, Zhu HL, Chen C. 2012. A novel hemoglobin-based oxygen carrier, polymerized porcine hemoglobin, inhibits H2O2-induced cytotoxicity of endothelial cells. Artif Organs. 36:151–160.
- Zhu HL, Dang XD, Yan KP, Dai PG, Ma J, Li Y, Chang TMS, Chen C. 2011. Pharmacodynamic study of polymerized porcine hemoglobin (pPolyHb) in a rat model of exchange transfusion. Artif Cells Blood Substit Immobil Biotechnol. 39:119–126.